RT @jsenior64: Meta-análisis de Cochrane. Juzguen ustedes los resultados. https://t.co/EAkfaqaJRI https://t.co/hL8aX1N8SO
RT @jsenior64: Meta-análisis de Cochrane. Juzguen ustedes los resultados. https://t.co/EAkfaqaJRI https://t.co/hL8aX1N8SO
Meta-análisis de Cochrane. Juzguen ustedes los resultados. https://t.co/EAkfaqaJRI https://t.co/hL8aX1N8SO
RT @Ricky_Turgeon: "Celebrating" 1 year of pointing out a major analysis error in this Cochrane review on drugs for HF with LVEF >40% witho…
RT @Ricky_Turgeon: "Celebrating" 1 year of pointing out a major analysis error in this Cochrane review on drugs for HF with LVEF >40% witho…
RT @Ricky_Turgeon: "Celebrating" 1 year of pointing out a major analysis error in this Cochrane review on drugs for HF with LVEF >40% witho…
"Celebrating" 1 year of pointing out a major analysis error in this Cochrane review on drugs for HF with LVEF >40% without author response, correction, or editorial action beyond making this comment publicly available for periodic shaming https://t.co/f
It's been >10 months since I sent this letter to the @cochranecollab regarding a simple but significant analysis error in their meta-analysis on drugs in HFpEF. I sent 2 further correspondences with 0 reply. What's happened to Cochrane? https://t.co/hxJ
HFpEFってMRA,ARNI,ARB,ACE-I,BBとどれもほとんど予後改善のエビデンスないってマジ…… https://t.co/4h8LQKBFTQ
Open Access UCL Research: Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction https://t.co/OQiDC7e1Jf
RT @CochraneHeart: We have published a new review update! Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chro…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
RT @drpatrickholmes: #HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉mo…
#HFpEF #CaReMe @cochranecollab review (41 RCTs, n=23,492) 👉possible ⤵️ CV☠️ with Beta-blockers (low certainty) 👉moderate certainty evidence that MRAs & sacubitril:valsartan ⤵️ 🏥💔 👉little or no effect on CV☠️ & QOL https://t.co/2f7GfTXH3H http
RT @CochraneHeart: We have published a new review update! Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chro…
RT @CochraneHeart: We have published a new review update! Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chro…
RT @CochraneLibrary: #BetaBlockers and inhibitors of the renin‐angiotensin aldosterone system for chronic #HeartFailure with preserved eje…
#BetaBlockers and inhibitors of the renin‐angiotensin aldosterone system for chronic #HeartFailure with preserved ejection fraction - https://t.co/fx7ZaC2rG5 - Updated #SystematicReview from @CochraneHeart includes evidence from 10 studies. https://t.co/Fn
Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction - Martin, N - 2021 | Cochrane Library https://t.co/tmhEfVgWa4
RT @CochraneLibrary: #BetaBlockers and inhibitors of the renin‐angiotensin aldosterone system for chronic #HeartFailure with preserved eje…
#BetaBlockers and inhibitors of the renin‐angiotensin aldosterone system for chronic #HeartFailure with preserved ejection fraction - https://t.co/UyBqfyIhzb - Updated #SystematicReview from @CochraneHeart includes evidence from 10 studies.
RT @Sefap_FAP: Betabloqueantes e inhibidores del eje renina angiotensina aldosterona en pac con ICC y FE conservada Vía @rincondesisifo
RT @rincondesisifo: (Cochrane) Betabloqueantes e inhibidores del eje renina angiotensina aldosterona en pac con ICC y FE conservada https:/…
Betabloqueantes e inhibidores del eje renina angiotensina aldosterona en pac con ICC y FE conservada Vía @rincondesisifo
RT @rincondesisifo: (Cochrane) Betabloqueantes e inhibidores del eje renina angiotensina aldosterona en pac con ICC y FE conservada https:/…
RT @rincondesisifo: (Cochrane) Betabloqueantes e inhibidores del eje renina angiotensina aldosterona en pac con ICC y FE conservada https:/…
RT @rincondesisifo: (Cochrane) Betabloqueantes e inhibidores del eje renina angiotensina aldosterona en pac con ICC y FE conservada https:/…
RT @rincondesisifo: (Cochrane) Betabloqueantes e inhibidores del eje renina angiotensina aldosterona en pac con ICC y FE conservada https:/…
(Cochrane) Betabloqueantes e inhibidores del eje renina angiotensina aldosterona en pac con ICC y FE conservada https://t.co/trEq4NwLXt Unos reducen la mortalidad. Otros, no... OJO!! https://t.co/SwJVgAW5Bj
RT @CochraneHeart: We have published a new review update! Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chro…
RT @CochraneHeart: We have published a new review update! Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chro…
RT @CochraneHeart: We have published a new review update! Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chro…
RT @CochraneHeart: We have published a new review update! Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chro…
RT @CochraneHeart: We have published a new review update! Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chro…
We have published a new review update! Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction - read the full review here: https://t.co/Wq4nCM43oo https://t.co/OrvKLz8sZO